Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
5.44
-0.12 (-2.16%)
At close: Nov 4, 2024, 4:00 PM
5.48
+0.04 (0.74%)
After-hours: Nov 4, 2024, 5:30 PM EST
Skye Bioscience Employees
Skye Bioscience had 11 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,844,374
Market Cap
165.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
The Joint | 794 |
biote | 194 |
BrainsWay | 134 |
Stereotaxis | 122 |
Black Diamond Therapeutics | 54 |
Acumen Pharmaceuticals | 52 |
Candel Therapeutics | 42 |
Sagimet Biosciences | 10 |
SKYE News
- 3 days ago - Skye Bioscience to Announce Third Quarter 2024 Results - GlobeNewsWire
- 14 days ago - Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences - GlobeNewsWire
- 26 days ago - 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore - Benzinga
- 2 months ago - Skye: Moving Weight Loss Drugs To The Next Level - Seeking Alpha
- 2 months ago - Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences - GlobeNewsWire
- 2 months ago - Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity - GlobeNewsWire
- 2 months ago - Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Accesswire